Activation of protein phosphatase 2A in FLT3+ acute myeloid leukemia cells enhances the cytotoxicity of FLT3 tyrosine kinase inhibitors.
about
FLT3 Inhibitors in Acute Myeloid Leukemia: Current Status and Future Directions.Therapeutic Targeting of PP2A.Functional importance of PP2A regulatory subunit loss in breast cancer.PPP2R1A regulated by PAX3/FOXO1 fusion contributes to the acquisition of aggressive behavior in PAX3/FOXO1-positive alveolar rhabdomyosarcoma.
P2860
Activation of protein phosphatase 2A in FLT3+ acute myeloid leukemia cells enhances the cytotoxicity of FLT3 tyrosine kinase inhibitors.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Activation of protein phosphat ...... T3 tyrosine kinase inhibitors.
@en
type
label
Activation of protein phosphat ...... T3 tyrosine kinase inhibitors.
@en
prefLabel
Activation of protein phosphat ...... T3 tyrosine kinase inhibitors.
@en
P2093
P2860
P50
P356
P1433
P1476
Activation of protein phosphat ...... LT3 tyrosine kinase inhibitors
@en
P2093
Amanda M Smith
Anoop Enjeti
Celeste Harrison
Daniel Thomas
Erwin M Lee
Hayley Flanagan
Jason A Powell
Jonathan Morris
Leonie K Ashman
Mark A Guthridge
P2860
P304
47465-47478
P356
10.18632/ONCOTARGET.10167
P407
P50
P577
2016-07-01T00:00:00Z